Northwest Investment Counselors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $16.3K | Buy |
+247
| New | +$16.3K | ﹤0.01% | 378 |
|
|
2024
Q2 | – | Sell |
-142
| Closed | -$13.6K | – | 256 |
|
|
2024
Q1 | $13.6K | Buy |
+142
| New | +$13.6K | ﹤0.01% | 350 |
|
|
2023
Q4 | – | Sell |
-1,061
| Closed | -$73.5K | – | 260 |
|
|
2023
Q3 | $73.5K | Buy |
1,061
+52
| +5% | +$3.6K | 0.02% | 193 |
|
|
2023
Q2 | $95.2K | Hold |
1,009
| – | – | 0.03% | 184 |
|
|
2023
Q1 | $83.5K | Sell |
1,009
-131
| -11% | -$10.8K | 0.02% | 197 |
|
|
2022
Q4 | $85.1K | Buy |
1,140
+1,050
| +1,167% | +$78.3K | 0.02% | 197 |
|
|
2022
Q3 | $7K | Sell |
90
-123
| -58% | -$9.57K | ﹤0.01% | 402 |
|
|
2022
Q2 | $20K | Hold |
213
| – | – | 0.01% | 298 |
|
|
2022
Q1 | $25K | Sell |
213
-21
| -9% | -$2.47K | 0.01% | 293 |
|
|
2021
Q4 | $30K | Buy |
+234
| New | +$30K | 0.01% | 277 |
|
|
2021
Q2 | – | Sell |
-234
| Closed | -$20K | – | 234 |
|
|
2021
Q1 | $20K | Buy |
+234
| New | +$20K | 0.01% | 300 |
|
|
2020
Q4 | – | Sell |
-234
| Closed | -$19K | – | 235 |
|
|
2020
Q3 | $19K | Buy |
+234
| New | +$19K | 0.01% | 274 |
|
|
2019
Q4 | – | Sell |
-66
| Closed | -$5K | – | 259 |
|
|
2019
Q3 | $5K | Buy |
+66
| New | +$5K | ﹤0.01% | 430 |
|